Eli Lilly and Company Website

Eli Lilly and Company

NYSE-LLY

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

22,319.5

24,539.8

28,318.4

28,541.4

34,124.1

38,922.8

Total Revenues % Chg.

3.8%

9.9%

15.4%

0.8%

19.6%

31.9%

Cost of Goods Sold, Total

4,721.2

5,483.3

6,973.1

6,629.8

7,082.2

7,491.8

Gross Profit

17,598.3

19,056.5

21,345.3

21,911.6

27,041.9

31,431

Selling General & Admin Expenses, Total

6,003.9

5,869.4

6,141.9

6,067.5

6,941.2

7,337

R&D Expenses

5,595

5,976.3

6,930.7

7,190.8

9,313.4

10,205.8

Other Operating Expenses, Total

11,598.9

11,845.7

13,072.6

13,258.3

16,254.6

17,542.8

Operating Income

5,999.4

7,210.8

8,272.7

8,653.3

10,787.3

13,888.2

Interest Expense, Total

-400.6

-359.6

-339.8

-331.6

-485.9

-626

Interest And Investment Income

80.4

33

25.4

62.8

173.6

176.5

Net Interest Expenses

-320.2

-326.6

-314.4

-268.8

-312.3

-449.5

Currency Exchange Gains (Loss)

-61.9

123.7

-204.6

-191.3

-26.4

-26.4

Other Non Operating Income (Expenses)

5.3

-319.2

256

177

-6.3

25.7

EBT, Excl. Unusual Items

5,622.6

6,688.7

8,009.7

8,370.2

10,442.3

13,438

Restructuring Charges

-77.8

-151.2

-13

-23

-45.5

-45.5

Merger & Related Restructuring Charges

—

—

—

—

—

-400.7

—

—

—

—

—

Gain (Loss) On Sale Of Investments

—

401.2

1,442.2

176.9

-410.7

-20.2

-83.5

Gain (Loss) On Sale Of Assets

—

—

—

—

309.8

—

—

—

—

—

Asset Writedown

—

—

—

—

—

—

—

—

—

—

In Process R&D Expenses

-239.6

-769.8

-970.1

-908.5

-3,799.8

-3,862.5

Legal Settlements

—

—

—

—

—

—

—

—

—

—

-435

Other Unusual Items

-349.6

20

-1,048

-221.6

-22.2

-22.2

EBT, Incl. Unusual Items

5,265.9

7,229.9

6,155.5

6,806.4

6,554.6

8,989.3

Income Tax Expense

628

1,036.2

573.8

561.6

1,314.2

1,647.1

Earnings From Continuing Operations

4,637.9

6,193.7

5,581.7

6,244.8

5,240.4

7,342.2

Earnings Of Discontinued Operations

—

—

—

3,680.5

—

—

—

—

—

Net Income

8,318.4

6,193.7

5,581.7

6,244.8

5,240.4

7,342.2

Net Income to Common Incl Extra Items

8,318.4

6,193.7

5,581.7

6,244.8

5,240.4

7,342.2

Net Income to Common Excl. Extra Items

4,637.9

6,193.7

5,581.7

6,244.8

5,240.4

7,342.2

Total Shares Outstanding

907.5

906.6

903.7

900.2

899.4

900.4

Weighted Avg. Shares Outstanding

931.1

907.6

907

901.7

900.2

900.4

Weighted Avg. Shares Outstanding Dil

935.7

912.5

911.7

904.6

903.3

903.8

EPS

8.9

6.8

6.2

6.9

5.8

8.2

EPS Diluted

8.9

6.8

6.1

6.9

5.8

8.1

EBITDA

7,232

8,534.7

9,820.3

10,175.8

12,314.6

15,501.9

Effective Tax Rate

11.9%

14.3%

9.3%

8.3%

20.1%

18.3%